peptide deals FAQ

Discounts exceeding 35% on research-grade peptides with published purity certificates almost never reflect genuine synthesis cost savings. They signal inventory clearance of compounds approaching expiration, failed batches being liquidated at cost, or baseline price inflation creating phantom discounts. Cross-reference the supplier's standard pricing from 60–90 days prior using archived catalog pages or third-party price tracking. If baseline prices increased 20%+ in February–March before the May promotion, the advertised discount is manufactured.

Order during October 2026 and refrigerate at 2–8°C until needed. Lyophilised peptides stored correctly maintain >97% potency for 12–18 months pre-reconstitution. The savings outweigh minimal storage requirements. Labs running quarterly procurement cycles should front-load October purchases to capture pricing advantage even if immediate use isn't planned. The certificate of analysis expiration doesn't start until reconstitution occurs.

Purchase during May promotions if the compound has 12+ month stability at −20°C and your storage maintains consistent temperature control with backup power. Peptides like Thymalin, MK 677, and Mazdutide retain 98%+ potency across 15–18 month storage periods when properly maintained. Avoid stockpiling neuropeptides or reconstituted formulations beyond 6-month usage windows. Degradation rates accelerate after initial stability periods even under ideal storage.

Do not purchase. A synthesis date is non-negotiable for determining remaining peptide shelf life. Without it, you cannot assess how much stability window remains or verify that the February discount reflects normal inventory turnover rather than age-based clearance. Reputable suppliers provide synthesis dates automatically because it's standard batch documentation. Refusal or inability to provide this information signals either poor record-keeping or intentional opacity about product age, both of which create unacceptable risk for research applications.

Isolate whether the replication failure stems from peptide purity variation or protocol differences by requesting batch-matched peptide for follow-up experiments. When dose-response curves shift between experiments, the first variable to control is peptide source. Using the exact same batch eliminates purity as a confounding variable. If replication succeeds with batch-matched peptide but fails with a new batch at stated purity, request comparative HPLC analysis between batches to identify impurity profile differences. Our experience shows that 2–3% shifts in specific impurity content. Even when total purity remains constant at 96%. Can alter IC50 values by 20–40% in competitive binding assays.

Request third-party verification before beginning your research protocol. Independent laboratories offer peptide purity testing via HPLC and mass spectrometry for $400–600 per sample. Expensive but far cheaper than three months of research time spent on protocols using degraded compounds. If the supplier refuses to provide retroactive COA documentation or claims proprietary synthesis prevents third-party testing, dispose of the compound and source from verified suppliers. Peptide research with unverified compounds produces irreproducible results that waste institutional resources and compromise publication credibility.

Request the full HPLC chromatogram showing retention time peaks for both the target peptide and any detected impurities. A generic "≥95% pure" certificate without chromatogram data suggests the supplier either didn't perform comprehensive analysis or is concealing impurity composition. The specific impurities matter because truncated sequences, deletion mutants, and substitution errors each affect receptor binding differently. 5% impurity from a single predictable truncation is manageable in dose calculations, but 5% split across unknown contaminants makes accurate molarity determination impossible. Labs conducting dose-response studies need to know whether impurities are biologically inert or active at the target receptor.

Price alone is insufficient for comparison. Compare synthesis dates, HPLC purity results, and shipping protocols. A 40% discount from a supplier with no documented cold-chain shipping is worth less than a 20% discount from a supplier with FedEx Priority and temperature monitoring. Request COAs from both suppliers and compare purity percentages. A peptide at 96% purity discounted 40% delivers lower effective value than a peptide at 99.2% purity discounted 25%. The cost per milligram of active compound, not the advertised discount percentage, determines value.

Contact the supplier directly and request the synthesis date and HPLC chromatogram before purchasing. Any supplier unwilling to provide batch-specific documentation during a promotion is either clearing old inventory or operating without proper quality control infrastructure. Peptide synthesis dates aren't proprietary information. They're standard QC metrics that legitimate 503B facilities and research suppliers maintain for regulatory traceability. If documentation isn't available, the discount isn't worth the reproducibility risk.

Compare documentation quality, not just price. Identical pricing across suppliers often indicates either coordinated inventory clearance or market-wide synthesis cost reductions. But quality verification remains supplier-specific. Request batch certificates from each vendor and compare: HPLC purity percentages (higher is better, minimum 98%), mass spectrometry molecular weight accuracy (within ±0.5 Da of theoretical), amino acid sequence confirmation (must match published structure exactly), and synthesis date (more recent is preferable). Two vendors selling the same compound at the same December price may be offering dramatically different quality levels based on synthesis protocols, storage conditions, and verification rigor.

Request updated HPLC verification before purchasing. A COA dated five months before an August promotion indicates either long-term storage where peptide degradation risk increases or a supplier clearing inventory without confirming current purity status. Lyophilised peptides stored at −20°C degrade at approximately 0.5–1.5% per year under ideal conditions, but storage temperature fluctuations compound this. A March COA showing 99.2% purity could represent 97.8–98.5% by August if storage wasn't continuously maintained at −20°C. Suppliers offering legitimate volume pricing provide updated testing; those clearing aged inventory rely on outdated documentation.

Request third-party testing documentation before purchasing. Not manufacturer certificates of analysis, but independent HPLC and mass spec performed by the supplier's contracted lab. Real Peptides publishes batch-specific reports with every order, showing retention time, peak purity, and molecular weight confirmation. If a supplier lists "≥98% purity" without providing the actual HPLC chromatogram, assume the purity claim is based on manufacturer data only.

Verify the synthesis date falls between November 2025 and January 2026, giving you at least 12 months of remaining shelf life from your March 2026 study start. Hexarelin contains oxidation-prone sequences, so request confirmation of continuous −20°C storage with no temperature excursions. If the batch was synthesised earlier than November 2025, the February promotion may still offer value for shorter pilot studies, but plan to purchase a fresh batch mid-study if your protocol extends beyond 6 months.

Peptide pricing tied to synthesis batch economics doesn't follow retail markdown cycles where prices drop progressively. January promotions reflect inventory rotation necessity at batch verification completion. Pricing after January returns to standard rates as inventory depletes and facilities shift to current-quarter synthesis. The lowest per-vial pricing occurs at quarterly inventory rotation windows (January, April, July) when verified batches from the previous quarter need clearance before new production scales up. Waiting for deeper discounts means purchasing at mid-quarter standard pricing when inventory rotation pressure no longer exists.

Lyophilised peptides stored at −20°C in sealed vials maintain stability for 18–24 months post-synthesis. Calculate your research timeline and order accordingly. Buying a 12-month supply during a November promotion makes sense if you have verified cold storage at −20°C and can use the compound within the stability window. Ordering a 24-month supply risks exceeding shelf life before use. Reconstituted peptides must be used within 28 days when stored at 2–8°C with bacteriostatic water, so bulk purchases of pre-mixed peptides are rarely cost-effective regardless of discount.

Verify storage conditions first. Lyophilized peptides exposed to humidity or temperature cycling can absorb moisture, triggering partial hydrolysis that degrades sequence integrity without visible changes. Reconstituted peptides stored above 8°C or longer than 28 days lose activity through oxidation and deamidation. If storage was correct, request a replacement batch with fresh HPLC verification. Real Peptides guarantees purity at time of shipment.